Showing 3221-3230 of 6634 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0909_05-php/22769/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0809_06-php/22785/Evaluating the Interleukin Antibodies and Their Future in Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0809_13-php/22791/New investigational therapies blocking IL-12/23 may offer new possibilities in the treatment of psoriatic disease.A User's Guide to the Field of Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0709_01-php/22796/All the facts you need to know about available biologic therapies, assembled in one place.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Is Topical Therapy for Psoriasis Resurging?
https://practicaldermatology.com/topics/psoriasis/PD0409_03-php/22841/While biologics have changed the way patients and physicians think about psoriasis, topical therapy remains important for a majority of patients.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?